|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| A61K 31/4439 | |||
| A61P 1/04 |
| (11) | Number of the document | 2102191 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07866107.1 |
| Date of filing the European patent application | 2007-12-28 | |
| (97) | Date of publication of the European application | 2009-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2012-11-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/089137 |
| Date | 2007-12-28 |
| (87) | Number | WO 2008/083341 |
| Date | 2008-07-10 |
| (30) | Number | Date | Country code |
| 877608 P | 2006-12-29 | US | |
| 887499 P | 2007-01-31 | US |
| (72) |
BRACKETT, John, M., US
JONAITIS, David, T., US
LAI, Wei, US
PARENT, Stephan, D., US
|
| (73) |
IL YANG PHARMACEUTICAL COMPANY, LTD.,
182-4 Hagal-dong Giheung-gu, Yongin-si, Gyeonggi-do 449-726,
KR
|
| (54) | CRYSTALLINE FORMS OF SOLVATED ILAPRAZOLE |
| CRYSTALLINE FORMS OF SOLVATED ILAPRAZOLE |